Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2022-04-29 00:00:00 ET · period of report 2022-01-01 · accession 0001104659-22-053578 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-29 | 2022-01-01 | FBIO | LOBELL J JAY | Dir | A - Grant | $0.00 | +100.0K | 1.24M | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 | 2022-01-01 | A | A | 100,000 | $0.00 | 1,236,000 | D | — | — | (F1) One-third of the shares will vest on each of January 1, 2023, 2024 and 2025, subject to continued service. |